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Introduction
Platelets play a critical role in hemostasis and are also important in the development of pathologic processes including atherosclerosis and arterial thrombosis.
1-2 Quantification of platelets in venous blood is a common laboratory measurement by automated hematology analyzers which utilize a reference range for a normal platelet count between 150000 to 450000 platelets per microliter of blood. 3 Both abnormally low (thrombocytopenia) and elevated (thrombocytosis) platelet counts are common findings in several illnesses including liver diseases, infections, autoimmune disorders and malignancies. 4 Morbidity and mortality associated with abnormal platelet counts is commonly thought to be due to such underlying diseases. However, there are very few data on the prevalence of thrombocytopenia and thrombocytosis and their independent effect on survival among elderly individuals.
The number of elderly individuals ≥ 65 years in the United States is expected to reach 71 million by 2030. 5 A similar aging trend is noted globally as by 2030 the worldwide population aged >65
years is projected to reach 973 million. 5 Consequently, an ever increasing number of asymptomatic elderly individuals will be found to have thrombocytopenia or thrombocytosis during routine complete blood cell count measurements. We therefore decided to study the prevalence and independent impact on survival of abnormal platelet counts in a large inner city outpatient elderly cohort comprised of different ethnicities and comorbid conditions. Previous studies have reported differences on platelet counts among different ethnicities. [6] [7] The present study population includes a high proportion of minorities that is both more representative of the changing national demographics and allows for a better delineation of the racial and ethnic implications of abnormal platelet counts on elderly survival.
Methods

Patient population
The study cohort consists of all patients ≥65 years of age seen at an outpatient clinic within the Montefiore medical system from January 1 st 1997 to May 1 st 2008 and who underwent a complete blood count within 3 months of the earliest visit date. Acutely ill patients were excluded by removing from the analysis all individuals who had been recently discharged from one of our inpatient facilities within 30 days prior to the index clinic visit. IRB approval for all study procedures was obtained from the Institutional Review Board of the Albert Einstein
College of Medicine and Montefiore Medical Center.
Independent Variables
All clinical data, including complete blood counts and comorbidities were retrieved using Clinical Looking Glass (CLG), a quality improvement health care surveillance software (Emerging Health Information Technology, Yonkers, NY). CLG is an interactive clinical information system developed at Montefiore Medical Center that integrates demographic, clinical, and administrative datasets and allows them to be reproduced in a programmable format for statistical access. Demographical data (age, gender and ethnicity) were determined by CLG based on registration information. Ethnicity was classified as either "non-Hispanic White" (nonhispanic Caucasian), "non-Hispanic Black" (African American), "Hispanic" or "other". The
Charlson comorbidity index (CCI), an extensively validated risk adjustment tool used for research that can measure the effect of multimorbidities on mortality using ICD-9 diagnosis codes, 8-9 was calculated using information derived from CLG. The CCI incorporates multiple comorbid conditions including myocardial infarct, congestive heart failure, peripheral vascular diseases, cerebrovascular diseases, dementia, chronic pulmonary diseases, rheumatologic diseases, peptic ulcer disease, liver disease, diabetes with or without complications, hemiplegia/paraplegia, renal disease, malignant tumors, metastatic diseases and AIDS. Ageadjusted CCI scores can be calculated, as previously described by Charlson et al., 8 by weighting and scoring each comorbid condition and then assigning 1 point for each additional decade of age over 40 years old. The validity of age-adjusted CCI for assessing the effect of comorbidities on survival rates has been studied more extensively than other similar measures and this index has been shown to perform well on outpatient primary care and community settings. 10 Mortality data were matched by CLG based on patient name, medical record and social security numbers.
The social security death registry was used by CLG to obtain the date of death. Because anemia and neutropenia may also independently affect survival, these covariates were also included in our analysis. Anemia was defined based on the World Health Organization (WHO) criteria of hemoglobin (Hb) <13g/dL in men, and <12g/dL in women. Patients were considered to have mild anemia if they met WHO criteria but had a Hb level that was >10g/dL, and severe anemia if the Hb level was ≤ 10g/dL. Neutropenia was defined as an absolute neutrophil count (ANC) <1500 per microliter of blood. Neutropenia was classified as "mild" if ANCs ranged between 1000 to 1499 per microliter, "moderate" for ANCs ranging between 500 to 999 per microliter and "severe" for ANCs <500 per microliter of venous blood. Thrombocytopenia and thrombocytosis were defined as a platelet count of <150000 per microliter or a platelet count of >450000 per microliter respectively.
Statistical Analysis
The Kolmogorov-Smirnov test was applied for analysis of variance in all continuous variables. 
Results
Baseline Characteristics and Prevalence of thrombocytopenia and thrombocytosis
A total of 36262 individuals (14038 men and 22224 women) met our inclusion criteria. The demographics and baseline characteristics, age-adjusted CCI scores, anemia and neutropenia rates of our study's population are shown in Table 1 Table 3 shows the results of multivariate analyses of the independent influence of patient demographical factors and comorbidities on thrombocytopenia and thrombocytosis rates respectively. The significant association of male gender with increased thrombocytopenia and with decreased thrombocytosis rates persisted in these adjusted models (p values <0.001). NonHispanic Whites also continued to be associated with higher thrombocytopenia rates after adjusting for covariates (p<0.001). In addition, patients with higher age-adjusted CCI scores were more likely to have thrombocytopenia or thrombocytosis (p<0.001 and p=0.045 respectively 
Predictors of abnormal platelet counts
Effect of abnormal platelet counts on overall survival
The multivariate survival analysis main effects model relating platelet counts to mortality is presented in 
Discussion
Previous reports have suggested an association between abnormal platelet counts with adverse clinical outcomes in various clinical conditions such as patients presenting with acute myocardial infarction, 11-12 community-acquired pneumonia 13 and solid cancers. [14] [15] [16] [17] However, very few studies have investigated the effect of platelet counts on the survival of healthy populations.
18-20
The present report is the largest investigation of the independent effects of abnormal platelet counts on overall survival to date. Our study took advantage of the availability of a very large database that incorporates clinical and laboratory data from an inner city outpatient elderly population comprising of different ethnicities and multiple comorbid conditions. We were thus able to determine that platelet counts have a U-shaped association with mortality after adjusting for comorbidities. Of note, CCI is the most extensively studied and validated comorbidity index currently available. 10, 21 In addition, our study's diverse population better elucidated the effect of ethnicity on mortality rates associated with abnormal platelet counts.
It should be noted that, to our knowledge, no other epidemiological study has reported the survival effect of thrombocytopenia or thrombocytosis among Hispanics. Interestingly, we found that the association of thrombocytosis with increased mortality was stronger among non-
Hispanic Whites compared to Hispanics or non-Hispanic Blacks. In addition, non-Hispanic
Blacks with thrombocytopenia demonstrated lower mortality risk compared to non-Hispanic Whites with thrombocytopenia. Previous work has demonstrated a strong genetic component to the variations between platelet counts among individuals and different ethnicities. [22] [23] Our results indicate that such genetic factors (or occult ethnicity-associated environmental factors) may also influence the effect of platelet abnormalities on overall survival. In addition, further exploratory analysis of our population cohort revealed that platelet counts of 125000 per microliter and 525000 per microliter may be more appropriate lower and upper platelet limits for defining the association of thrombocytopenia and thrombocytosis respectively with overall mortality risk among non-Hispanic Blacks. Indeed, using these thresholds confers similar prognostic value with regards to overall survival among non-Hispanic Blacks aged Although we have clearly shown that both thrombocytopenia and thrombocytosis are associated with decreased overall survival, the mechanisms mediating this effect remain to be elucidated. It is likely that in at least some of these cases, further clinical investigation may reveal occult disease processes that can affect mortality. It is also conceivable that abnormal platelet counts may directly play a role in pathophysiologic processes (e.g. via platelet involvement in atherosclerotic plaque formation). The linearity of the respective survival curves (Figure 1 ) and the fact that thrombocytopenia and thrombocytosis were independently associated with increased mortality over a long period may indicate that these conditions are associated with long-term pathophysiologic changes rather than acting as proxies for other unmeasured disorders. Whether treatment of thrombocytopenia or thrombocytosis would have any effect on outcomes remains to be determined.
Our study was conducted in a general elderly population with the only exclusion criterion being recent hospitalization in order to avoid potential biases caused by the inclusion of acutely ill individuals. Thus, the present results can be applicable to other outpatient populations and are reflective of the natural history and mortality effects of incidentally discovered abnormal platelet counts among the elderly. Racial and gender disparities were noted in our study population as men and non-Hispanic Blacks were more likely to have higher CCI scores. In our analysis, nonHispanic Whites and males had lower platelet counts compared to all other ethnicities and females respectively. These observations are consistent with prior reports of gender and racial differences in platelet counts 6, 22 and further support the generalizability of our findings.
Notably, we also found that an alarmingly high proportion of elderly non-Hispanic White males (13.5%) is thrombocytopenic. Further investigation will be required to elucidate the causes of this observed difference in platelet counts. As expected, higher age-adjusted CCI scores were independently associated with increased mortality. Furthermore, our results replicated the wellestablished finding that, in developed countries, elderly women have longer overall survival compared to elderly males. 24 We also found that a considerable proportion of our population carried other hematological abnormalities such as anemia and severe neutropenia which were also independently associated with shorter overall survival in our population. Future investigation should thus also focus on the mechanisms associated with these cell line abnormalities and their independent effect on mortality.
A number of variables were shown in the present study to be independently associated with abnormal platelet counts. Our findings confirm the significant association between male gender and non-Hispanic White ethnicity with higher rates of thrombocytopenia even after adjusting for all other covariates. Furthermore, increasing comorbidity scores were found to be predictive of higher rates of thrombocytopenia and thrombocytosis. This finding is consistent with the well known associations between abnormal platelet counts and the diverse clinical conditions accounted for in the present study including cancer, liver diseases and rheumatologic diseases. 4 Both anemia and neutropenia were found to be associated with thrombocytopenia, indicating the presence of bone marrow failure syndromes in such patients. Anemia and severe neutropenia were also related to thrombocytosis which in most of these cases is likely reactive in nature and secondary to a variety of disorders including neoplasms, iron deficiency and immune-mediated diseases. 4 The present study is limited by its observational nature which prevents the determination of causality. Although this report is unique in its extensive control of comorbidities known to influence platelet count, we do not have specific information on the etiology of the platelet count abnormalities. Furthermore, we were unable to determine the specific causes of death for our patient cohort. Baseline thrombocytopenia and thrombocytosis were defined based on a single measurement, although it should be noted that a large amount of evidence points to the considerable intra-individual stability of steady state platelet counts. 22, 25 The present study also has a number of strengths. It analyzed data from a very large and diverse population of elderly patients which facilitated multivariate analysis. In addition, the study's patients were seen at various inner city outpatient facilities within the Montefiore medical system which encompasses a broad range of treating physicians and settings consequently making our results more generalizable.
In conclusion, the present study demonstrated that both thrombocytosis and thrombocytopenia independently predicted mortality in a large outpatient cohort of inner city elderly subjects and this effect was heterogeneous across different ethnicities. Future areas of investigation should determine the mechanisms by which platelet count abnormalities are associated with decreased overall survival. LOESS regression model showing the association between platelet count (horizontal axis) and the log relative hazard ratio for overall mortality (vertical axis) for each ethnicity after adjusting for gender, anemia, neutropenia and age-adjusted Charlson comorbidity index. The shaded areas around each curve delimit the 95% confidence intervals.
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